The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2SEVENTY BIO INC | COMMON STOCK | 901384107 | 5,522,892 | 1,408,901 | SH | SOLE | 1,408,901 | 0 | 0 | |||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 23,290,000 | 3,400,000 | SH | SOLE | 3,400,000 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 13,456,545 | 5,701,926 | SH | SOLE | 5,701,926 | 0 | 0 | |||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 15,930,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | 7,456,914 | 2,485,638 | SH | SOLE | 2,485,638 | 0 | 0 | |||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 3,054,511 | 1,642,210 | SH | SOLE | 1,642,210 | 0 | 0 | |||
| CABALETTA BIO INC | COM | 12674W109 | 30,440,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | |||
| CARA THERAPEUTICS INC | COM | 140755109 | 39,725 | 23,646 | SH | SOLE | 23,646 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 37,934,916 | 1,275,552 | SH | SOLE | 1,275,552 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 13,627,278 | 913,969 | SH | SOLE | 913,969 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 62,602,964 | 1,332,545 | SH | SOLE | 1,332,545 | 0 | 0 | |||
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 13,514,550 | 915,000 | SH | SOLE | 915,000 | 0 | 0 | |||
| EQRX INC | COM | 26886C107 | 22,207,932 | 10,003,573 | SH | SOLE | 10,003,573 | 0 | 0 | |||
| INVIVYD INC | COM | 00534A102 | 3,293,252 | 1,937,207 | SH | SOLE | 1,937,207 | 0 | 0 | |||
| MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 11,520,017 | 1,431,058 | SH | SOLE | 1,431,058 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 11,002,865 | 8,663,673 | SH | SOLE | 8,663,673 | 0 | 0 | |||
| NATERA INC | COM | 632307104 | 30,983,717 | 700,197 | SH | SOLE | 700,197 | 0 | 0 | |||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 6,320,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 96,883,695 | 10,473,913 | SH | SOLE | 10,473,913 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 190,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 14,327,860 | 1,822,883 | SH | SOLE | 1,822,883 | 0 | 0 | |||
| NUVALENT INC | COM | 670703107 | 164,446,964 | 3,577,267 | SH | SOLE | 3,577,267 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 99,856,146 | 4,784,674 | SH | SOLE | 4,784,674 | 0 | 0 | |||
| RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 9,109,325 | 8,434,560 | SH | SOLE | 8,434,560 | 0 | 0 | |||
| SAVARA INC | COM | 805111101 | 53,799,799 | 14,232,751 | SH | SOLE | 14,232,751 | 0 | 0 | |||
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 7,888,663 | 3,130,422 | SH | SOLE | 3,130,422 | 0 | 0 | |||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 71,239,818 | 3,081,307 | SH | SOLE | 3,081,307 | 0 | 0 | |||
| SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 8,392,541 | 2,124,694 | SH | SOLE | 2,124,694 | 0 | 0 | |||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 32,571,385 | 2,892,663 | SH | SOLE | 2,892,663 | 0 | 0 | |||
| X4 PHARMACEUTICALS INC | COM | 98420X103 | 17,397,041 | 15,960,588 | SH | SOLE | 15,960,588 | 0 | 0 | |||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 5,919,421 | 2,805,413 | SH | SOLE | 2,805,413 | 0 | 0 | |||